Schizophrenia Clinical Trials in Bentonville, Arkansas

6 studies are recruiting for schizophrenia in Bentonville, Arkansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

    The purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with Schizophrenia

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Pillar Clinical Research - Bentonville, Bentonville, Arkansas
    Locations
    59 in total
    Run by
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company

    See if you can join NCT07686263 on ClinicalTrials.gov

  2. 52-week Open Label Safety-Tolerability Study

    Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Pillar Clinical Research, Bentonville, Arkansas
    Locations
    23 in total
    Run by
    LB Pharmaceuticals Inc.

    See if you can join NCT07369154 on ClinicalTrials.gov

  3. A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

    Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Pillar Clinical Research LLC - Bentonville Site, Bentonville, Arkansas
    Locations
    73 in total
    Run by
    Otsuka Pharmaceutical Development & Commercialization, Inc.

    See if you can join NCT06894212 on ClinicalTrials.gov

  4. Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

    The purpose of this study is to assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Pillar Clinical Research LLC, Bentonville, Arkansas
    Locations
    16 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07467993 on ClinicalTrials.gov

  5. Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

    This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult patients with an acute exacerbation of schizophrenia.

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Pillar Clinical Research, Bentonville, Arkansas
    Locations
    13 in total
    Run by
    LB Pharmaceuticals Inc.

    See if you can join NCT07363577 on ClinicalTrials.gov

  6. Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

    This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg or 50 mg once daily over 4 weeks, then in the long-term flexible doses 15-50mg daily over a period o…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Reviva site, Bentonville, Arkansas
    Locations
    18 in total
    Run by
    Reviva Pharmaceuticals

    See if you can join NCT05184335 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.